USD
$0.00
(0.00%
)At Close (As of Oct 13, 2025)
$6.51B
Market Cap
41.84
P/E Ratio
0.57
EPS
$28.00
52 Week High
$17.07
52 Week Low
HEALTHCARE
Sector
Field | Value (EUR) |
---|---|
Gross Profit | $302M |
Total Revenue | $1.1B |
Cost Of Revenue | $802M |
Costof Goods And Services Sold | $802M |
Operating Income | $161M |
Selling General And Administrative | $94M |
Research And Development | $32M |
Operating Expenses | $141M |
Investment Income Net | - |
Net Interest Income | -$5.8M |
Interest Income | $1.7M |
Interest Expense | $6.9M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $81M |
Income Before Tax | $160M |
Income Tax Expense | $43M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $118M |
Comprehensive Income Net Of Tax | - |
Ebit | $167M |
Ebitda | $248M |
Net Income | $118M |
Field | Value (EUR) |
---|---|
Total Assets | $2.3B |
Total Current Assets | $880M |
Cash And Cash Equivalents At Carrying Value | $98M |
Cash And Short Term Investments | $98M |
Inventory | $245M |
Current Net Receivables | $530M |
Total Non Current Assets | $1.4B |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $34M |
Intangible Assets Excluding Goodwill | $34M |
Goodwill | $50M |
Investments | - |
Long Term Investments | $5.6M |
Short Term Investments | $0 |
Other Current Assets | $6.8M |
Other Non Current Assets | - |
Total Liabilities | $924M |
Total Current Liabilities | $477M |
Current Accounts Payable | $231M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $112M |
Total Non Current Liabilities | $447M |
Capital Lease Obligations | $17M |
Long Term Debt | $305M |
Current Long Term Debt | $107M |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $429M |
Other Current Liabilities | $58M |
Other Non Current Liabilities | $63M |
Total Shareholder Equity | $1.4B |
Treasury Stock | - |
Retained Earnings | $863M |
Common Stock | $22M |
Common Stock Shares Outstanding | $273M |
Field | Value (EUR) |
---|---|
Operating Cashflow | $156M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $81M |
Capital Expenditures | $314M |
Change In Receivables | - |
Change In Inventory | $12M |
Profit Loss | - |
Cashflow From Investment | -$310M |
Cashflow From Financing | $183M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | $14M |
Dividend Payout Common Stock | $14M |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | $160M |
Field | Value (EUR) |
---|---|
Gross Profit | $302M |
Total Revenue | $1.1B |
Cost Of Revenue | $802M |
Costof Goods And Services Sold | $802M |
Operating Income | $161M |
Selling General And Administrative | $94M |
Research And Development | $32M |
Operating Expenses | $141M |
Investment Income Net | - |
Net Interest Income | -$5.8M |
Interest Income | $1.7M |
Interest Expense | $6.9M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $81M |
Income Before Tax | $160M |
Income Tax Expense | $43M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $118M |
Comprehensive Income Net Of Tax | - |
Ebit | $167M |
Ebitda | $248M |
Net Income | $118M |
Field | Value |
---|---|
Ex Dividend Date | 2025-06-05 |
Declaration Date | None |
Record Date | None |
Payment Date | None |
Amount | 0.062 |
Sector: HEALTHCARE
Industry: MEDICAL INSTRUMENTS & SUPPLIES
None